Danaher | DHR - Srodki Pieniężne I Ekwiwalent

Cena Akcji
171.16
Dzienna Zmiana
-4.50 -2.56%
Miesięcznie
-11.31%
Rocznie
-9.79%
Q2 Prognozy TE
167.62




Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 31M 2025-12
Align Technology USD 1.06B 35.07M 2026-03
Becton, Dickinson and Co. USD 813M 73M 2026-03
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Danaher USD 5.7B 1.09B 2026-03
Dentsply International USD 190M 136M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
ESCO Technologies USD 103.82M 2.47M 2025-12
Fortive USD 356.1M 19.4M 2026-03
Henry Schein USD 156M 20M 2025-12
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 7.98B 1.05B 2026-03
IQVIA Holdings USD 1.95B 33M 2026-03
Keysight Technologies USD 2.18B 305M 2025-12
Laboratory Of America USD 981.1M 448.8M 2026-03
Medtronic USD 1.15B 135M 2025-12
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
OraSure Technologies USD 176.96M 22.31M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Roper Industries USD 382.9M 85.5M 2026-03
Stryker USD 2.88B 1.13B 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 462M 125.83M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03